Disparities in chronic spontaneous urticaria: Eligibility for drug reimbursement associated with clinical outcomes
-
Published:2024-05
Issue:2
Volume:3
Page:100243
-
ISSN:2772-8293
-
Container-title:Journal of Allergy and Clinical Immunology: Global
-
language:en
-
Short-container-title:Journal of Allergy and Clinical Immunology: Global
Author:
Mak Hugo W.F.ORCID,
Chiang Valerie,
Chan Elsie T.S.,
Lee Elaine,
Yim Jackie S.H.,
Lam Dorothy L.Y.,
Li Philip H.ORCID
Reference10 articles.
1. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report;Maurer;Allergy,2011
2. The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU;Maurer;Allergy,2017
3. Li TS, Hui HKS, Kan AKC, Yeung MHY, Wong JCY, Chiang V, Li PH. Prospective Assessment of Penicillin Allergy (PAPA): evaluating the performance of penicillin allergy testing and post-delabelling outcomes among Hong Kong Chinese [e-pub ahead of print]. Asian Pac J Allergy Immunol https://doi.org/10.12932/AP-270922-1469. Accessed October 17, 2023.
4. Chronic spontaneous urticaria in Hong Kong: clinical characteristics, real-world practice and implications for COVID-19 vaccination;Kan;Allergy Asthma Immunol Res,2023
5. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria;Zuberbier;Allergy,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献